Brain atrophy in relapsing-remitting multiple sclerosis:: Fractional volumetric analysis of gray matter and white matter

被引:79
作者
Ge, YL
Grossman, RI
Udupa, JK
Babb, JS
Nyúl, LG
Kolson, DL
机构
[1] Univ Penn, Med Ctr, Dept Radiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Neurol, Philadelphia, PA 19104 USA
[3] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA
关键词
brain; gray matter; MR; volume; white matter; sclerosis; multiple;
D O I
10.1148/radiol.2203001776
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine the fractional brain tissue volume changes in the gray matter and white matter of patients with relapsing-remitting multiple sclerosis (MS) and to correlate these measurements with clinical disability and total lesion load. MATERIALS AND METHODS: Thirty patients with relapsing-remitting MS and 25 healthy control subjects underwent magnetic resonance imaging. Fractional brain tissue volumes (tissue volume relative to total intracranial volume) were obtained from the total segmented gray matter and white matter in each group and were analyzed. RESULTS: The fractional volume of white matter versus that of gray matter was significantly lower (-6.4%) in patients with MS (P < .0001) than in control subjects. Neither gray matter nor white matter fractional volume measurements correlated with clinical disability in the patients with MS. CONCLUSION: Loss of brain parenchymal volume in patients with relapsing-remitting MS is predominantly confined to white matter. Analysis of fractional brain tissue volumes provides additional information useful in characterizing MS and may have potential in evaluating treatment strategies.
引用
收藏
页码:606 / 610
页数:5
相关论文
共 29 条
[1]   THE LONGSTANDING MS LESION - A QUANTITATIVE MRI AND ELECTRON-MICROSCOPIC STUDY [J].
BARNES, D ;
MUNRO, PMG ;
YOUL, BD ;
PRINEAS, JW ;
MCDONALD, WI .
BRAIN, 1991, 114 :1271-1280
[2]  
Catalaa I, 1999, AM J NEURORADIOL, V20, P1613
[3]   SERIAL PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN ACUTE MULTIPLE-SCLEROSIS LESIONS [J].
DAVIE, CA ;
HAWKINS, CP ;
BARKER, GJ ;
BRENNAN, A ;
TOFTS, PS ;
MILLER, DH ;
MCDONALD, WI .
BRAIN, 1994, 117 :49-58
[4]   MULTIPLE-SCLEROSIS AND CORPUS-CALLOSUM ATROPHY - RELATIONSHIP OF MRI FINDINGS TO CLINICAL-DATA [J].
DIETEMANN, JL ;
BEIGELMAN, C ;
RUMBACH, L ;
VOUGE, M ;
TAJAHMADY, T ;
FAUBERT, C ;
JEUNG, MY ;
WACKENHEIM, A .
NEURORADIOLOGY, 1988, 30 (06) :478-480
[5]  
DUQUETTE P, 1995, NEUROLOGY, V45, P1277
[6]   Progressive cerebral atrophy in MS - A serial study using registered, volumetric MRI [J].
Fox, NC ;
Jenkins, R ;
Leary, SM ;
Stevenson, VL ;
Losseff, NA ;
Crum, WR ;
Harvey, RJ ;
Rossor, MN ;
Miller, DH ;
Thompson, AJ .
NEUROLOGY, 2000, 54 (04) :807-812
[7]   Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS - Quantitative MR assessment [J].
Ge, Y ;
Grossman, RI ;
Udupa, JK ;
Fulton, J ;
Constantinescu, CS ;
Gonzales-Scarano, F ;
Babb, JS ;
Mannon, LJ ;
Kolson, DL ;
Cohen, JA .
NEUROLOGY, 2000, 54 (04) :813-817
[8]   Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: Longitudinal quantitative analysis [J].
Ge, YL ;
Grossman, RI ;
Udupa, JK ;
Wei, LG ;
Mannon, LJ ;
Polansky, M ;
Kolson, DL .
RADIOLOGY, 2000, 214 (03) :665-670
[9]  
Ge YL, 2001, AM J NEURORADIOL, V22, P470
[10]  
Hollander M, 1973, NONPARAMETRIC STAT M, P191